PMV PHARMACEUTICALS, INC. Deferred Tax Liabilities, Property, Plant and Equipment
PMV PHARMACEUTICALS, INC. (PMVP) had Deferred Tax Liabilities, Property, Plant and Equipment of $27.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2026-03-06
- 2025-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $27.00K.
- 2024-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $44.00K.
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $219.00K.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $29.00K.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment |
|---|---|
| 2025-12-31 | $27.00K 10-K · filed 2026-03-06 |
| 2024-12-31 | $44.00K 10-K · filed 2026-03-06 |
| 2023-12-31 | $219.00K 10-K · filed 2025-03-03 |
| 2022-12-31 | $29.00K 10-K · filed 2024-02-29 |
| 2021-12-31 | $37.00K 10-K · filed 2023-03-01 |
| 2020-12-31 | $45.00K 10-K · filed 2022-03-01 |
| 2019-12-31 | $61.00K 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |